InspireMD Company Insiders
| NSPR Stock | USD 1.85 0.13 6.57% |
InspireMD employs about 65 people. The company is managed by 19 executives with a total tenure of roughly 107 years, averaging almost 5.0 years of service per executive, having 3.42 employees per reported executive. Discussion of InspireMD's management performance can provide insight into the enterprise performance.
| Alan Milinazzo CEO CEO and President and Director |
| Sol Barer Chairman Independent Chairman of the Board |
InspireMD |
InspireMD Management Team Effectiveness
The company has return on total asset (ROA) of (0.3656) % which means that it has lost $0.3656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7001) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/24/2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 04/24/2024, Total Current Assets is likely to grow to about 46.4 M, while Non Currrent Assets Other are likely to drop slightly above 654.2 K.As of 04/24/2024, Common Stock Shares Outstanding is likely to grow to about 25.5 M, while Net Loss is likely to drop (22.3 M).
InspireMD Workforce Comparison
InspireMD is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 105. InspireMD totals roughly 65.0 in number of employees claiming about 62% of equities under Health Care industry.
InspireMD Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, InspireMD insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Paul Stuka over two months ago Acquisition by Paul Stuka of 43548 shares of InspireMD subject to Rule 16b-3 | ||
Verta Patrick over six months ago InspireMD exotic insider transaction detected | ||
Paul Stuka over six months ago Acquisition by Paul Stuka of 238950 shares of InspireMD subject to Rule 16b-3 | ||
Paul Stuka over six months ago Acquisition by Paul Stuka of 225680 shares of InspireMD subject to Rule 16b-3 |
InspireMD Notable Stakeholders
An InspireMD stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as InspireMD often face trade-offs trying to please all of them. InspireMD's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting InspireMD's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marvin Slosman | CEO President | Profile | |
| Alan Milinazzo | CEO and President and Director | Profile | |
| Sol Barer | Independent Chairman of the Board | Profile | |
| Isaac Blech | Vice Chairman of the Board | Profile | |
| Eli Bar | Senior Vice President - Research and Development and Chief Technical Officer of InspireMD Ltd | Profile | |
| Agustin Gago | Executive Vice President Chief Commercial Officer | Profile | |
| Craig Shore | CFO, Chief Admin. Officer, Secretary and Treasurer | Profile | |
| James Loughlin | Independent Director | Profile | |
| Campbell Rogers | Independent Director | Profile | |
| Michael Berman | Independent Director | Profile | |
| Thomas Kester | Director | Profile | |
| Paul Stuka | Independent Director | Profile | |
| James Barry | COO, Executive VP and Director | Profile | |
| Roei Samuri | VP Operations | Profile | |
| Shane Gleason | Chief Officer | Profile | |
| DVM MD | Executive Affairs | Profile | |
| Andrea Tommasoli | Chief Officer | Profile | |
| Amir Kohen | Vice Resources | Profile | |
| Pete Ligotti | Executive America | Profile |
About InspireMD Management Performance
The success or failure of an entity such as InspireMD often depends on how effective the management is. InspireMD management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of InspireMD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the InspireMD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.50) | (0.53) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.50) | (0.48) |
The data published in InspireMD's official financial statements usually reflect InspireMD's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of InspireMD. For example, before you start analyzing numbers published by InspireMD accountants, it's critical to develop an understanding of what InspireMD's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of InspireMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InspireMD's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in InspireMD's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InspireMD. Please utilize our Beneish M Score to check the likelihood of InspireMD's management manipulating its earnings.
InspireMD Workforce Analysis
Traditionally, organizations such as InspireMD use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare InspireMD within its industry.InspireMD Manpower Efficiency
Return on InspireMD Manpower
| Revenue Per Employee | 95.5K | |
| Revenue Per Executive | 326.6K | |
| Net Loss Per Employee | 306.4K | |
| Net Loss Per Executive | 1M | |
| Working Capital Per Employee | 586.8K | |
| Working Capital Per Executive | 2M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.